Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.

Fortun J, Go JC, Li J, Amici SA, Dunn WA Jr, Notterpek L.

Neurobiol Dis. 2006 Apr;22(1):153-64. Epub 2005 Dec 2.

PMID:
16326107
2.

Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants.

Khajavi M, Inoue K, Wiszniewski W, Ohyama T, Snipes GJ, Lupski JR.

Am J Hum Genet. 2005 Nov;77(5):841-50. Epub 2005 Sep 30.

3.

Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.

Kobsar I, Hasenpusch-Theil K, Wessig C, Müller HW, Martini R.

J Neurosci Res. 2005 Sep 15;81(6):857-64.

PMID:
16041800
4.

PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Inoue K.

Neurogenetics. 2005 Feb;6(1):1-16. Epub 2004 Dec 31. Review.

PMID:
15627202
5.

Modulation of neurodegeneration by molecular chaperones.

Muchowski PJ, Wacker JL.

Nat Rev Neurosci. 2005 Jan;6(1):11-22. Review.

PMID:
15611723
6.

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.

Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM.

J Biol Chem. 2005 Feb 18;280(7):5892-901. Epub 2004 Dec 7.

7.

Cell signaling pathways altered by natural chemopreventive agents.

Sarkar FH, Li Y.

Mutat Res. 2004 Nov 2;555(1-2):53-64. Review.

PMID:
15476851
8.

Localization and functional analyses of the MLC1 protein involved in megalencephalic leukoencephalopathy with subcortical cysts.

Teijido O, Martínez A, Pusch M, Zorzano A, Soriano E, Del Río JA, Palacín M, Estévez R.

Hum Mol Genet. 2004 Nov 1;13(21):2581-94. Epub 2004 Sep 14.

PMID:
15367490
9.

Calnexin suppresses GD3 synthase-induced apoptosis.

Tomassini B, Malisan F, Franchi L, Nicolò C, Calvo GB, Saito T, Testi R.

FASEB J. 2004 Oct;18(13):1553-5. Epub 2004 Aug 19.

PMID:
15319364
10.

Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models.

Song Y, Sonawane ND, Salinas D, Qian L, Pedemonte N, Galietta LJ, Verkman AS.

J Biol Chem. 2004 Sep 24;279(39):40629-33. Epub 2004 Jul 26.

11.

Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.

Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glöckner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ.

Science. 2004 Apr 23;304(5670):600-2.

12.

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontés M.

Nat Med. 2004 Apr;10(4):396-401. Epub 2004 Mar 21.

PMID:
15034573
13.

Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).

Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA.

Nat Med. 2003 Dec;9(12):1533-7. Epub 2003 Nov 9.

PMID:
14608378
14.

The eye photoreceptor protein rhodopsin. Structural implications for retinal disease.

Garriga P, Manyosa J.

FEBS Lett. 2002 Sep 25;528(1-3):17-22. Review.

15.

Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases.

Dickson KM, Bergeron JJ, Shames I, Colby J, Nguyen DT, Chevet E, Thomas DY, Snipes GJ.

Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9852-7. Epub 2002 Jul 15.

16.

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY.

Anticancer Res. 2001 Jul-Aug;21(4B):2895-900.

PMID:
11712783
17.
18.

PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.

Colby J, Nicholson R, Dickson KM, Orfali W, Naef R, Suter U, Snipes GJ.

Neurobiol Dis. 2000 Dec;7(6 Pt B):561-73.

PMID:
11114256
19.

Function of tetraspan proteins in the myelin sheath.

Bronstein JM.

Curr Opin Neurobiol. 2000 Oct;10(5):552-7. Review.

PMID:
11084316
20.

Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy.

Isaacs AM, Davies KE, Hunter AJ, Nolan PM, Vizor L, Peters J, Gale DG, Kelsell DP, Latham ID, Chase JM, Fisher EM, Bouzyk MM, Potter A, Masih M, Walsh FS, Sims MA, Doncaster KE, Parsons CA, Martin J, Brown SD, Rastan S, Spurr NK, Gray IC.

Hum Mol Genet. 2000 Jul 22;9(12):1865-71.

PMID:
10915775

Supplemental Content

Support Center